Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference70 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015
2. SEER Cancer statistics review, 1975-2007;Altekruse,2010
3. Cancer statistics, 2016;Siegel;CA: A Cancer Journal for Clinicians,2016
4. The global decrease in cancer mortality: trends and disparities;Hashim;Ann Oncol,2016
5. A clinical-severity staging system for patients with lung cancer;Feinstein;Medicine,1990
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Protozoa Parasite-Derived Protein Adjuvant Is Effective in Immunization with Cancer Cells to Activate the Cancer-Specific Protective Immunity and Inhibit the Cancer Growth in a Murine Model of Colorectal Cancer;Cells;2024-01-06
2. Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System;Value in Health Regional Issues;2023-01
3. Predicting the efficacy of immune checkpoint inhibitors monotherapy in advanced non-small cell lung cancer: a machine learning method based on multidimensional data;Neoplasma;2023
4. LncRNA-ATB inhibits the proliferation and invasion of NSCLC cells by regulating MiR-200s expression;Tropical Journal of Pharmaceutical Research;2022-11-03
5. Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer;Frontiers in Immunology;2022-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3